You are here: HomeSolutionsCountriesUSA
print my pages

Market Research for United States of America

Euromonitor publishes reports on industries, consumers and demographics in the US.

  • Industry specific reports offer insight into market size and market share in US; as well as industry trends in each specific industry.
  • The Consumer Lifestyles in US report examines national lifestyle habits, ranging from health and living standards, income and earning patterns, eating and drinking habits, to home ownership trends.
  • USA in 2030: The Future Demographic contains information on long term population changes, population by gender, consumer segment: babies, infants, toddlers, children, tweenagers, teenagers, studying age, young-adults, middle-aged adults, and the elderly.

Filter Results

Total: (378)

results

 

Strategy Briefing

Midlife Women: Embracing Power and Avoiding Invisibility in Global Consumer Markets

This report explores the lives of midlife women. Despite their number, spending power and contribution to the labour force, many wonder why they are ignored. In mature markets midlifers are the big spending Boomers. In emerging markets they are a ...

May 2013 | US$2,600| Add to cart | View details ›

Country Report

Weight Management in the US

The main ingredient in Alli, Xenical, experienced manufacturing issues for half of 2012, which led to significant declines in growth to OTC obesity due to its unavailability. As a result, OTC obesity experienced a 35% decline in current value sales ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Wound Care in the US

Unlike many other consumer health categories, where trends such as the ageing population, stressful lifestyles and higher incidence of allergies exert a notable influence on sales, there are fewer major demographic drivers in wound care. While ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Adult Mouth Care in the US

Dry mouth products, particularly Biotene, steadily increased in share of adult mouth care, while mouth sore and other oral pain remedies, such as Orajel and Anbesol, consistently falling in sales. Although not caused by normal ageing, dry mouth is ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Analgesics in the US

After two years of recalls from Johnson & Johnson’s McNeil consumer health subsidiary, 2012 was expected to be a year of recovery in analgesics. Instead, production failures grew even more widespread. Novartis announced its own major recalls, ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Calming and Sleeping in the US

Calming and sleeping was yet another category affected by the manufacturing failures at McNeil and Novartis. McNeil’s Simply Sleep essentially disappeared, while formerly dominant Tylenol PM experienced massive declines in sales. Novartis’s Excedrin ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in the US

Cough, cold and allergy (hay fever) remedies faced several challenges in 2012. First, the 2011-2012 flu season was unusually mild. Warmer temperatures, which are less hospitable to flu viruses and also drive people out of confined indoor spaces where...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Dermatologicals in the US

After cough, cold and allergy (hay fever) remedies, analgesics, and digestive remedies, dermatologicals is the fourth most lucrative consumer health category in the US, accounting for 13% share of OTC value sales in 2012. Unlike these other ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Digestive Remedies in the US

2012 was another turbulent year for digestive remedies. McNeil’s ongoing manufacturing quality issues led to unpredictable or non-existent availability of such popular heartburn and indigestion brands as Pepcid, Mylanta and Rolaids, as well as ...

Apr 2013 | US$900| Add to cart | View details ›

Country Report

Ear Care in the US

The sale of Debrox to Prestige Brands marked GlaxoSmithKline’s departure from ear care in the US. Given that GlaxoSmithKline formerly led sales, the move represented a strategic shake-up in a category that witnessed very little development over the ...

Apr 2013 | US$900| Add to cart | View details ›
Page 
12345...38>

Books more ›

Statistical Reference Handbook

Consumer Americas 2013

Oct 2012

Statistical Reference Handbook

International Marketing Data and Statistics 2013

Nov 2012